Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyPediatric Oncology and HematologyProtocol groupOther Solid Tumors (ped.)TransplantationDiseaseNeuroblastomaStem Cell Transplantation, AutologousSubgroupAge < 1 yearAge > 1 yearMYCN amplificationWeight < 10 kgICD10C47.-Z94.80MeSHNeuroblastomaTransplantation, AutologousSequenceChemotherapyChemo-substanceCarboplatinEtoposide phosphateMelphalanChemo-substanceCarboplatinEtoposide phosphateMelphalanChemo-substanceCarboplatinEtoposide phosphateMelphalanChemo-substanceCarboplatinEtoposide phosphateMelphalanNo. Substances3 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleNo. Substances7Protocol classificationTherapy classificationStudy protocol, currentIntensityHochdosis, bei autologer SZTTherapy indicationFirst lineTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorCaron HNDiseaseNeuroblastom, Kinder unter 1 Jahr oder unter 10 kg und MYCN-Amplifikation, MegatherapieNeuroblastom, Kinder über 1 Jahr, MegatherapieOriginDCOG NBL 2009Protokolle in Überarbeitung 2 protocols foundPAED Melphalan 45 / Etoposide Phosphate 40 / Carboplatin 500, Neuroblastoma, autologous Stem Cell Transplantation (PID2887 V1.1)PAED Melphalan 1.5 / Etoposide Phosphate 40 / Carboplatin 16.6, Neuroblastoma, Stem Cell Transplantation, Autologous (PID2888 V1.1)
